Retatrutide dosed at 20mg per vial and tested by HPLC with a reputable 3rd party

     Retatrutide dosed at 20mg per vial and tested by HPLC and with a reputable 3rd party, Janoshik. We have found 99%+ purity and are using 3rd party Janoshik for testing. If you have any questions about the testing - please message us!

    Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Retatrutide targets multiple receptors in the body, including GLP-1, GIP, and glucagon receptors, whereas semaglutide only targets the GLP-1 receptor. This broader targeting allows retatrutide to potentially offer greater weight loss and metabolic benefits

 .DISCLAIMER: ALL PEPTIDES ARE SOLD FOR REASEARCH PURPOSE ONLY AND HAVE TO BE SOLD NOT FOR HUMAN CONSUMPTION.